---
figid: PMC9644706__10020_2022_560_Fig3_HTML
pmcid: PMC9644706
image_filename: 10020_2022_560_Fig3_HTML.jpg
figure_link: /pmc/articles/PMC9644706/figure/Fig3/
number: Fig. 3
figure_title: ''
caption: Role of FADD in cancer progression. FADD dysregulation contributes to cancer
  progression by various mechanisms, including crosstalk with oncogenic signaling
  pathway, induction of inflammation, inhibition of apoptosis, promotion of proliferation,
  modulation of cell cycle, and enhancement of drug resistance
article_title: FADD as a key molecular player in cancer progression.
citation: Ying Liu, et al. Mol Med. 2022;28:132.
year: '2022'

doi: 10.1186/s10020-022-00560-y
journal_title: Molecular Medicine
journal_nlm_ta: Mol Med
publisher_name: BioMed Central

keywords:
- FADD
- Inflammation
- Drug resistance
- Biomarker
- Therapeutic target

---
